Evexia Lifecare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 315.73 million compared to INR 447.77 million a year ago. Revenue was INR 315.73 million compared to INR 464.78 million a year ago. Net loss was INR 13.48 million compared to net income of INR 15.62 million a year ago. Basic loss per share from continuing operations was INR 0.02 compared to basic earnings per share from continuing operations of INR 0.025 a year ago. Diluted loss per share from continuing operations was INR 0.02 compared to diluted earnings per share from continuing operations of INR 0.025 a year ago.